ArticleFrontiers in genetics2022

TGFβ2 is a Prognostic Biomarker for Gastric Cancer and is Associated With Methylation and Immunotherapy Responses.

Bangling Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.